|
1
|
Vengoji R, Macha MA, Batra SK and Shonka
NA: Natural products: A hope for glioblastoma patients. Oncotarget.
9:22194–22219. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ouanouki A, Lamy S and Annabi B:
Periostin, a signal transduction intermediate in TGF-β-induced EMT
in U-87MG human glioblastoma cells, and its inhibition by
anthocyanidins. Oncotarget. 9:22023–22037. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu J, Wang WM, Zhang XL, Du QH, Li HG and
Zhang Y: Effect of downregulated lncRNA NBAT1 on the biological
behavior of glioblastoma cells. Eur Rev Med Pharmacol Sci.
22:2715–2722. 2018.PubMed/NCBI
|
|
4
|
Jayachandran A, Jonathan GE, Patel B and
Prabhu K: Primary spinal cord glioblastoma metastasizing to the
cerebellum: A missed entity. Neurol India. 66:854–857. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huang L, Boling W and Zhang JH: Hyperbaric
oxygen therapy as adjunctive strategy in treatment of glioblastoma
multiforme. Med Gas Res. 8:24–28. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Paulmurugan R, Afjei R, Sekar TV, Babikir
HA and Massoud TF: A protein folding molecular imaging biosensor
monitors the effects of drugs that restore mutant p53 structure and
its downstream function in glioblastoma cells. Oncotarget.
9:21495–21511. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tanaka H, Yamaguchi T, Hachiya K, Miwa K,
Shinoda J, Hayashi M, Ogawa S, Nishibori H, Goshima S and Matsuo M:
11C-methionine positron emission tomography for target
delineation of recurrent glioblastoma in re-irradiation planning.
Rep Pract Oncol Radiother. 23:215–219. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Puchalski RB, Shah N, Miller J, Dalley R,
Nomura SR, Yoon JG, Smith KA, Lankerovich M, Bertagnolli D, Bickley
K, et al: An anatomic transcriptional atlas of human glioblastoma.
Science. 360:660–663. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schulze M, Hutterer M, Sabo A, Hoja S,
Lorenz J, Rothhammer-Hampl T, Herold-Mende C, Floßbach L, Monoranu
C and Riemenschneider MJ: Chronophin regulates active vitamin B6
levels and transcriptomic features of glioblastoma cell lines
cultured under non-adherent, serum-free conditions. BMC Cancer.
18:5242018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Di Sebastiano AR, Deweyert A, Benoit S,
Iredale E, Xu H, De Oliveira C, Wong E, Schmid S and Hebb MO:
Preclinical outcomes of intratumoral modulation therapy for
glioblastoma. Sci Rep. 8:73012018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang X, Sun S, Tong X, Ma Q, Di H, Fu T,
Sun Z, Cai Y, Fan W, Wu Q, et al: MiRNA-154-5p inhibits cell
proliferation and metastasis by targeting PIWIL1 in glioblastoma.
Brain Res. 1676:69–76. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hinske LC, Heyn J, Hübner M, Rink J,
Hirschberger S and Kreth S: Intronic miRNA-641 controls its host
Gene's pathway PI3K/AKT and this relationship is dysfunctional in
glioblastoma multiforme. Biochem Biophys Res Commun. 489:477–483.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang X, Zhang X, Hu S, Zheng M, Zhang J,
Zhao J, Zhang X, Yan B, Jia L, Zhao J, et al: Identification of
miRNA-7 by genome-wide analysis as a critical sensitizer for
TRAIL-induced apoptosis in glioblastoma cells. Nucleic Acids Res.
45:5930–5944. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li LY, Xiao J, Liu Q and Xia K: Parecoxib
inhibits glioblastoma cell proliferation, migration and invasion by
upregulating miRNA-29c. Biol Open. 6:311–316. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bing ZT, Yang GH, Xiong J, Guo L and Yang
L: Identify signature regulatory network for glioblastoma prognosis
by integrative mRNA and miRNA co-expression analysis. IET Syst
Biol. 10:244–251. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hu HQ, Sun LG and Guo WJ: Decreased
miRNA-146a in glioblastoma multiforme and regulation of cell
proliferation and apoptosis by target Notch1. Int J Biol Markers.
31:e270–e275. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu W, Li P, Xu Q and Wang C: Regulation
of miR-181 on chemotherapy-resistant cervical cancer cells. Int J
Clin Experimental Pathol. 9:4560–4565. 2016.
|
|
18
|
Zhou WY, Chen JC, Jiao TT, Hui N and Qi X:
MicroRNA-181 targets Yin Yang 1 expression and inhibits cervical
cancer progression. Mol Med Rep. 11:4541–4546. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang X, Xin Z, Xu Y and Ma J: Upregulated
miRNA-622 inhibited cell proliferation, motility, and invasion via
repressing Kirsten rat sarcoma in glioblastoma. Tumour Biol.
37:5963–5970. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bo LJ, Wei B, Li ZH, Wang ZF, Gao Z and
Miao Z: Bioinformatics analysis of miRNA expression profile between
primary and recurrent glioblastoma. Eur Rev Med Pharmacol Sci.
19:3579–3586. 2015.PubMed/NCBI
|
|
22
|
Kouri FM, Ritner C and Stegh AH: miRNA-182
and the regulation of the glioblastoma phenotype-toward miRNA-based
precision therapeutics. Cell Cycle. 14:3794–3800. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
LeBlanc VC and Morin P: Exploring
miRNA-associated signatures with diagnostic relevance in
glioblastoma multiforme and breast cancer patients. J Clin Med.
4:1612–1630. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu SL, Fu X, Huang J, Jia TT, Zong FY, Mu
SR, Zhu H, Yan Y, Qiu S, Wu Q, et al: Genome-wide analysis of
YB-1-RNA interactions reveals a novel role of YB-1 in miRNA
processing in glioblastoma multiforme. Nucleic Acids Res.
43:8516–8528. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Das S, Kohr M, Dunkerly-Eyring B, Lee DI,
Bedja D, Kent OA, Leung AK, Henao-Mejia J, Flavell RA and
Steenbergen C: Divergent effects of miR-181 family members on
myocardial function through protective cytosolic and detrimental
mitochondrial microRNA targets. J Am Heart Assoc. 6(pii):
e0046942017.PubMed/NCBI
|
|
26
|
Strotbek M, Schmid S, Sànchezgonzàlez I,
Boerries M, Busch H and Olayioye MA: miR-181 elevates Akt signaling
by co-targeting PHLPP2 and INPP4B phosphatases in luminal breast
cancer. Int J Cancer. 140:2310–2320. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu J, Xing Y and Rong L: miR-181
regulates cisplatin-resistant non-small cell lung cancer via
downregulation of autophagy through the PTEN/PI3K/AKT pathway.
Oncol Rep. 39:1631–1639. 2018.PubMed/NCBI
|
|
28
|
Su R, Lin HS, Zhang XH, Yin XL, Ning HM,
Liu B, Zhai PF, Gong JN, Shen C, Song L, et al: MiR-181 family:
Regulators of myeloid differentiation and acute myeloid leukemia as
well as potential therapeutic targets. Oncogene. 34:3226–3239.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ge B, Li J, Wei Z, Sun T, Song Y and Khan
NU: Functional expression of CCL8 and its interaction with
chemokine receptor CCR3. BMC Immunol. 18:542017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee JU, Cheong HS, Shim EY, Bae DJ, Chang
HS, Uh ST, Kim YH, Park JS, Lee B, Shin HD and Park CS: Gene
profile of fibroblasts identify relation of CCL8 with idiopathic
pulmonary fibrosis. Respir Res. 18:32017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Halvorsen EC, Hamilton MJ, Young A,
Wadsworth BJ, LePard NE, Lee HN, Firmino N, Collier JL and
Bennewith KL: Maraviroc decreases CCL8-mediated migration of
CCR5(+) regulatory T cells and reduces metastatic tumor growth in
the lungs. Oncoimmunology. 5:e11503982016. View Article : Google Scholar : PubMed/NCBI
|
